fig1

Endocrine therapy in metastatic breast cancer-more than just CDK4/6 inhibitors

Figure 1. Mechanism of CDK4/6 inhibition; Modified from Li et al., 2020[5]. FGFR: Fibroblast growth factor receptor; ER: estrogen receptor; AI: aromatase inhibitor; CDK4/6: cyclin-dependent kinases 4/6; P: phosphorylation; Rb: retinoblastoma protein; E2F: transcription factor E2F

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/